Cargando…
Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases
The aim of the present study was to evaluate the risk factors for postoperative complications following liver resection for colorectal cancer liver metastases. Patients who underwent hepatic resection for colorectal cancer liver metastases were stratified according to chemotherapy administration and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574199/ https://www.ncbi.nlm.nih.gov/pubmed/28855987 http://dx.doi.org/10.3892/mco.2017.1358 |
_version_ | 1783259782960906240 |
---|---|
author | Massani, Marco Capovilla, Giovanni Ruffolo, Cesare Bonariol, Roberta Maccatrozzo, Paola Tuci, Francesco Battistella, Giuseppe Grazi, Gian Luca Bassi, Nicolò |
author_facet | Massani, Marco Capovilla, Giovanni Ruffolo, Cesare Bonariol, Roberta Maccatrozzo, Paola Tuci, Francesco Battistella, Giuseppe Grazi, Gian Luca Bassi, Nicolò |
author_sort | Massani, Marco |
collection | PubMed |
description | The aim of the present study was to evaluate the risk factors for postoperative complications following liver resection for colorectal cancer liver metastases. Patients who underwent hepatic resection for colorectal cancer liver metastases were stratified according to chemotherapy administration and body mass index (BMI) to eliminate potential confounding factors. A univariate analysis was conducted to identify potential risk factors for postoperative complications following liver resection. Variables that exhibited a potential association were evaluated by multivariable logistic regression analysis to identify those independently associated with postoperative morbidity. Between January 2012 and March 2012, 100 patients underwent hepatic resection for liver metastases from colorectal carcinoma at the Treviso Regional Hospital (Treviso, Italy) and at the Regina Elena National Cancer Institute (Rome, Italy). Of the 100 patients, 61 received preoperative oxaliplatin- or irinotecan-based chemotherapy. A total of 25 the patients had a BMI of ≥28 kg/m(2). On univariate analysis, BMI ≥28 kg/m(2) was found to be positively correlated with the presence of steatosis (P<0.01) and steatohepatitis (P<0.01). The administration of preoperative chemotherapy was correlated with the development of steatosis (P<0.01), steatohepatitis (P=0.02) and postoperative complications (P=0.03). Even following stratification for the use of preoperative chemotherapy, BMI ≥28 kg/m(2) maintained its positive association with steatohepatitis. On multivariate analysis, steatohepatitis (P=0.005, HR=0.118, 95% CI: 0.027–0.518) and blood transfusions (P=0.001, HR=0.131, 95% CI: 0.038–0.452) were independently associated with postoperative complications. BMI ≥28 kg/m(2) (P=0.004, HR=8.30, 95% CI: 2.39–28.7) and irinotecan treatment (P=0.016, HR=0.16, 95% CI: 0.037–0.711) were independent risk factors for steatohepatitis. In conclusion, steatohepatitis and perioperative blood transfusions were found to be the main determinant of postoperative complications following liver resection for colorectal liver metastases. Overweight patients may be more prone to the cytotoxic effects of irinotecan, harboring a higher risk of developing steatohepatitis. |
format | Online Article Text |
id | pubmed-5574199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-55741992017-08-30 Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases Massani, Marco Capovilla, Giovanni Ruffolo, Cesare Bonariol, Roberta Maccatrozzo, Paola Tuci, Francesco Battistella, Giuseppe Grazi, Gian Luca Bassi, Nicolò Mol Clin Oncol Articles The aim of the present study was to evaluate the risk factors for postoperative complications following liver resection for colorectal cancer liver metastases. Patients who underwent hepatic resection for colorectal cancer liver metastases were stratified according to chemotherapy administration and body mass index (BMI) to eliminate potential confounding factors. A univariate analysis was conducted to identify potential risk factors for postoperative complications following liver resection. Variables that exhibited a potential association were evaluated by multivariable logistic regression analysis to identify those independently associated with postoperative morbidity. Between January 2012 and March 2012, 100 patients underwent hepatic resection for liver metastases from colorectal carcinoma at the Treviso Regional Hospital (Treviso, Italy) and at the Regina Elena National Cancer Institute (Rome, Italy). Of the 100 patients, 61 received preoperative oxaliplatin- or irinotecan-based chemotherapy. A total of 25 the patients had a BMI of ≥28 kg/m(2). On univariate analysis, BMI ≥28 kg/m(2) was found to be positively correlated with the presence of steatosis (P<0.01) and steatohepatitis (P<0.01). The administration of preoperative chemotherapy was correlated with the development of steatosis (P<0.01), steatohepatitis (P=0.02) and postoperative complications (P=0.03). Even following stratification for the use of preoperative chemotherapy, BMI ≥28 kg/m(2) maintained its positive association with steatohepatitis. On multivariate analysis, steatohepatitis (P=0.005, HR=0.118, 95% CI: 0.027–0.518) and blood transfusions (P=0.001, HR=0.131, 95% CI: 0.038–0.452) were independently associated with postoperative complications. BMI ≥28 kg/m(2) (P=0.004, HR=8.30, 95% CI: 2.39–28.7) and irinotecan treatment (P=0.016, HR=0.16, 95% CI: 0.037–0.711) were independent risk factors for steatohepatitis. In conclusion, steatohepatitis and perioperative blood transfusions were found to be the main determinant of postoperative complications following liver resection for colorectal liver metastases. Overweight patients may be more prone to the cytotoxic effects of irinotecan, harboring a higher risk of developing steatohepatitis. D.A. Spandidos 2017-10 2017-08-01 /pmc/articles/PMC5574199/ /pubmed/28855987 http://dx.doi.org/10.3892/mco.2017.1358 Text en Copyright: © Massani et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Massani, Marco Capovilla, Giovanni Ruffolo, Cesare Bonariol, Roberta Maccatrozzo, Paola Tuci, Francesco Battistella, Giuseppe Grazi, Gian Luca Bassi, Nicolò Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title | Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title_full | Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title_fullStr | Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title_full_unstemmed | Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title_short | Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
title_sort | blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574199/ https://www.ncbi.nlm.nih.gov/pubmed/28855987 http://dx.doi.org/10.3892/mco.2017.1358 |
work_keys_str_mv | AT massanimarco bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT capovillagiovanni bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT ruffolocesare bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT bonariolroberta bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT maccatrozzopaola bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT tucifrancesco bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT battistellagiuseppe bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT grazigianluca bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases AT bassinicolo bloodtransfusionsandsteatohepatitisareindependentriskfactorsforcomplicationsfollowingliverresectionforcolorectalcancerlivermetastases |